AKSO HEALTH GR. (SPADR)/3 (8HX) - Total Liabilities
Based on the latest financial reports, AKSO HEALTH GR. (SPADR)/3 (8HX) has total liabilities worth €13.73 Million EUR (≈ $16.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 8HX net assets growth trend to track the company's year-over-year net asset growth rate.
AKSO HEALTH GR. (SPADR)/3 - Total Liabilities Trend (2022–2025)
This chart illustrates how AKSO HEALTH GR. (SPADR)/3's total liabilities have evolved over time, based on quarterly financial data. See AKSO HEALTH GR. (SPADR)/3 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
AKSO HEALTH GR. (SPADR)/3 Competitors by Total Liabilities
The table below lists competitors of AKSO HEALTH GR. (SPADR)/3 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korean Reinsu
KO:003690
|
Korea | ₩10.58 Trillion |
|
Vanchip (Tianjin) Technology Co. Ltd. A
SHG:688153
|
China | CN¥461.04 Million |
|
Marqeta Inc
NASDAQ:MQ
|
USA | $734.43 Million |
|
Innoviva Inc
NASDAQ:INVA
|
USA | $462.32 Million |
|
B.Grimm Power Public Company Limited
BK:BGRIM
|
Thailand | ฿133.69 Billion |
|
DoubleVerify Holdings Inc
NYSE:DV
|
USA | $193.14 Million |
|
Suning Commerce Group Co Ltd
SHE:002024
|
China | CN¥99.66 Billion |
|
Xinjiang Zhongtai Chemical Co Ltd
SHE:002092
|
China | CN¥52.74 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down AKSO HEALTH GR. (SPADR)/3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AKSO HEALTH GR. (SPADR)/3 (8HX) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AKSO HEALTH GR. (SPADR)/3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AKSO HEALTH GR. (SPADR)/3 (2022–2025)
The table below shows the annual total liabilities of AKSO HEALTH GR. (SPADR)/3 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €15.80 Million ≈ $18.47 Million |
+339.69% |
| 2024-03-31 | €3.59 Million ≈ $4.20 Million |
-69.07% |
| 2023-03-31 | €11.62 Million ≈ $13.59 Million |
-77.00% |
| 2022-03-31 | €50.52 Million ≈ $59.06 Million |
-- |
About AKSO HEALTH GR. (SPADR)/3
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more